1 October 2024

Highlights in Medicinal Chemistry V

Organised by:

SCI’s Fine Chemicals Group

SCI, London, UK

Register your interest

This meeting aims to showcase vignettes of modern medicinal chemistry to bring new thinking to the subject, challenge perceptions and encourage scientific interaction between researchers. The short presentation format of the meeting also aims to provide a focussed forum to promote examples of medicinal chemistry excellence.


This meeting is targeted at academic and industrial scientists engaged in all aspects of the drug discovery process and those interested in broadening their knowledge at the forefront of medicinal chemistry.

Confirmed speakers
Professor Ed Tate, Imperial College London  
Dr Ingo Hartung, Merck Healthcare
Dr Thomas Pesnot, Concept Life Sciences
Dr Suzanne O’Connor, Centre for Targeted Protein Degradation Dundee

The programme will be confirmed in due course.

SCI’s Fine Chemicals Group are committed to promoting diversity and equality in the chemical sciences. We aim to identify high quality speakers for all our conferences with full inclusivity where attendees from all backgrounds are welcome. We are open to offering flexible presentation options. 

Sponsorship and exhibition information

For further information and prices, please email conferences@soci.org.

Call for oral abstracts

Abstracts for focussed 20-minute talks with contributions from the whole field of medicinal chemistry are now invited: please submit a one-page abstract to conferences@soci.org by Thursday 28 March 2024, with “Highlights V – short talk abstract” in the subject line. An abstract template can be downloaded here.

Venue and Contact


14/15 Belgrave Square

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

Accredited cpd Centre - The CPD Standards Office - CPD Provider 41057 - www.cpdstandards.com



Organising committee
Dr Nicola Chessum, SCI / Boehringer Ingelheim RCV GmbH & Co KG
Dr Helen Horsley, SCI / UCB
Dr Sarah Major,  SCI / Dark Blue Therapeutics
Dr Joanne Pinder, SCI / Vertex Pharmaceuticals (Europe) Ltd
Dr Hugh Tawell, SCI / Domainex